Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

2021: A Breakout Year for Uranium Investments?

(Image via Anfield Energy Inc.) The Athabasca Basin is perhaps best known as the world’s leading source of high-grade uranium and currently supplies about 20% of the world’s uranium. It is a region in the Canadian Shield that enco...
Stockhouse Editorial | February 26, 2021 |

Target Price Raised on Metals Firm 'Growing Substantial High-Grade Project'

The newly announced resource update and what it means in terms of project economics is captured in a ROTH Capital Partners report. In a March 18 research note, analyst Jake Sekelsky reported that ROTH Capital Partners raised its target price on Buy-rated SilverCrest Me...
Streetwise Reports | March 22, 2019 |

Houston-Based Oil & Gas Producer Sets Goal to Become Wholly Carbon Neutral

A Raymond James report considers both what it would take to achieve this and how doing so could uplift profitability in relation to the company's use of enhanced oil recovery. In an April 2 research note, analyst Pavel Molchanov guesstimated the potential profitability ...
Streetwise Reports | April 8, 2019 |

US vs. Global Sector Rotation - What Next? Part 1

Our research team, at www.TheTechnicalTraders.com , have been pouring over the charts and data to identify what is likely to happen over the next 60+ days in terms of global stock market volatility vs. the US stock market expectations. Recently, we posted a research article h...
Chris Vermeulen | May 21, 2019 |

Miner Releases Resource for Arizona Zinc-Lead-Silver Deposit

A BMO Capital Markets report gave the new figures for tons and grades and compared them to ones in a prior estimate. In a June 17 research note, BMO Capital Markets analyst Edward Sterck reported that South32 Ltd. (S32:ASX; S32:LSE) published a mineral...
Streetwise Reports | June 20, 2019 |

Gold Gets a Boost of Rocket Fuel From Negative Bond Yields

Ladies and gentlemen, we have liftoff! After breaking out of a five-year trading range, the price of gold surged above $1,400 an ounce last week for the first time since 2013 on expectations of a U.S. rate cut. The 10-year Treasury yield fell to around 2 percent,...
Frank Holmes | June 24, 2019 |

Biotech Firm ''Creating Innovative Solutions' for Female Health

The company's most advanced assets are discussed in a Dawson James Securities report. In a July 18 research note, Dawson James Securities analyst Jason Kolbert reported he assumed coverage on Daré Bioscience Inc. (DARE:NASDAQ) , and in doing so, rated it Bu...
Streetwise Reports | July 24, 2019 |

Gold Explorer and Developer 'On Track to Repeat Atlantic Gold Success'

Observations and takeaways from a visit to the company's Bulgaria properties are given in a Haywood report. In an Aug. 21 research note, Haywood analyst Mick Carew reported that Velocity Minerals Ltd. (VLC:TSX.V; VLCJF:OTCQB) is "is on track to repeat Atlantic Gold ...
Streetwise Reports | August 30, 2019 |

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. Shares of Ovid Therapeutics Inc. (OVID:NASDAQ) are tra...
Streetwise Reports | September 25, 2019 |

Analyst: Acquisition by Colorado-Based Specialty Pharma 'Could Bolster Revenue 400%'

The benefits and terms of the agreement are outlined in a Ladenburg Thalmann report. In a Sept. 18 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Aytu BioScience Inc. (AYTU:NASDAQ) signed a definitive agreement to acquire Innovus Pharmaceutic...
Streetwise Reports | September 25, 2019 |
1 2 3 4